Literature DB >> 2821908

Specific receptor sites for platelet activating factor on rat liver plasma membranes.

S B Hwang1.   

Abstract

The binding of 3H-labeled 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF) to isolated rat liver plasma membranes and its inhibition by PAF agonists and receptor antagonists was demonstrated. The specific binding was readily saturable with a high affinity. The equilibrium dissociation constant (KD) value was 0.51 (+/- 0.14) nM and the maximal number of binding sites (Bmax) was estimated to be 141 (+/- 18) fmol/mg protein. The binding site was PAF specific-biologically inactive enantiomer was practically inactive. Two PAF-like receptor antagonists, Ono-6240 and CV-3988, and two PAF-unlike receptor antagonists, L-652,731 and kadsurenone, also displaced the binding of [3H]PAF to rat liver plasma membranes but their relative potencies in this system differed from those found in other receptor systems. Mg2+ potentiated [3H]PAF binding but inhibited it at concentrations higher than 10 mM. Both Na+ and K+ inhibited the Mg2+-potentiated binding, an ionic effect which was different from that found in rabbit platelets. These results suggest that rat livers contain PAF-specific receptors, and the receptors in rat livers are different from those found in other receptor systems.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821908     DOI: 10.1016/0003-9861(87)90574-1

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists.

Authors:  M T Domingo; F Piro; C Broquet; E Auclair; P E Chabrier; P Braquet
Journal:  Lipids       Date:  1992-08       Impact factor: 1.880

2.  PAF effects on transmembrane signaling pathways in rat Kupffer cells.

Authors:  C R Gandhi; M S Olson
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

Review 3.  L-659,989: a useful probe in the detection of multiple conformational states of PAF receptors.

Authors:  S B Hwang; M H Lam
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

Review 4.  Platelet-activating factor: receptors and signal transduction.

Authors:  W Chao; M S Olson
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

5.  Different receptors mediate the hepatic catabolism of tissue-type plasminogen activator and urokinase.

Authors:  J Krause; W Seydel; G Heinzel; P Tanswell
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

6.  Autoradiographic localization of platelet-activating factor (PAF) binding sites in the rabbit endometrium during the peri-implantation period.

Authors:  G B Kudolo; M Kasamo; M J Harper
Journal:  Cell Tissue Res       Date:  1991-08       Impact factor: 5.249

7.  Roles of Ca2+ in human neutrophil responses to receptor agonists.

Authors:  J T O'Flaherty; A G Rossi; D P Jacobson; J F Redman
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

8.  Characterization of the binding of plasminogen activators to plasma membranes from human liver.

Authors:  G Nguyen; S J Self; C Camani; E K Kruithof
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

9.  Effect of platelet-activating factor on lipoprotein lipase and blood lipids.

Authors:  K Mimura; S Yukawa; Y Mori; K Okada; M Mune; O Nishikawa; A Hibino; M Sonobe; T Goto; H Nomoto
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

10.  Characterization of platelet-activating factor binding to human airway epithelial cells: modulation by fatty acids and ion-channel blockers.

Authors:  J X Kang; S F Man; A J Hirsh; M T Clandinin
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.